Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Diamedica Therapeutics Inc
(NQ:
DMAC
)
3.961
-0.019 (-0.47%)
Streaming Delayed Price
Updated: 9:39 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Diamedica Therapeutics Inc
< Previous
1
2
Next >
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q2 2024
August 07, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
DMAC Stock Earnings: DiaMedica Therapeutics Beats EPS for Q1 2024
May 08, 2024
DMAC stock results show that DiaMedica Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023
March 19, 2024
DMAC stock results show that DiaMedica Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Recap: DiaMedica Therapeutics Q4 Earnings
March 19, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 25, 2023
Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.
Via
InvestorPlace
Earnings Preview: DiaMedica Therapeutics
May 12, 2023
Via
Benzinga
DiaMedica Therapeutics's Earnings Outlook
March 27, 2023
Via
Benzinga
FDA Institutes Clinical Hold On DiaMedica's Late-Stage Stroke Trial - Read Why
July 07, 2022
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
Earnings Outlook For DiaMedica Therapeutics
November 10, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023
June 22, 2023
Via
Benzinga
DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199
June 21, 2023
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a
Via
Benzinga
$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
December 02, 2022
The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also...
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
DiaMedica Therapeutics: Q2 Earnings Insights
August 10, 2022
DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
August 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
DiaMedica Therapeutics Earnings Preview
August 09, 2022
DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More
July 22, 2022
U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
July 08, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Via
Benzinga
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
July 07, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 07, 2022
Thursday's session saw 49 companies set new 52-week lows.
Via
Benzinga
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
July 07, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims.
Via
Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
Via
Benzinga
Why U.S. Stocks Are Trading Higher After Rise In Jobless Claims
July 07, 2022
U.S. stocks traded higher this morning, following the release of data on initial jobless claims.
Via
Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
July 07, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Upgrades
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 07, 2022
Good morning, trader! We're taking a look at the biggest pre-market stock movers for Thursday that investors need to know about!
Via
InvestorPlace
Why Is GameStop Surging By Around 10%? 22 Stocks Moving In Thursday's Pre-Market Session
July 07, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.